Literature DB >> 9455691

Resveratrol has no effect on lipoprotein profile and does not prevent peroxidation of serum lipids in normal rats.

J F Turrens1, J Lariccia, M G Nair.   

Abstract

Trans-resveratrol, one of the antioxidants found in red wine, has been the subject of controversial reports regarding its protective role against cardiovascular diseases. In this study we synthesized trans-resveratrol and injected it to rats (20 and 40 mg/kg body weight, once a day for 21 days, i.p.) to determine its effect on the serum lipid profile. Synthetic trans-resveratrol was an effective antioxidant in vitro against hydroxyl radical (I50 = 33 microM). Resveratrol treatment, however, did not have any effect on either the lipid profile or on Cu+2-dependent formation of thiobarbituric-acid-reactive substances (TBARS) from protein-associated lipids. Since the amount of resveratrol used in these experiments was orders of magnitude higher than the amounts found in wine, these results suggest that if resveratrol has any effect against coronary heart diseases, it is not related to its antioxidant role on lipids or to changes in lipoprotein profile.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9455691     DOI: 10.3109/10715769709097859

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  11 in total

1.  Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet.

Authors:  Amin Shah; Laura M Reyes; Jude S Morton; David Fung; Jillian Schneider; Sandra T Davidge
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

2.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03

3.  Immunotoxicity studies of trans-resveratrol in male B6C3F1/N mice.

Authors:  Madelyn C Huang; Kimber L White; Susan A Elmore; Tai L Guo; Dori Germolec
Journal:  J Immunotoxicol       Date:  2020-12       Impact factor: 3.000

4.  Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men.

Authors:  Jesper Olesen; Lasse Gliemann; Rasmus Biensø; Jakob Schmidt; Ylva Hellsten; Henriette Pilegaard
Journal:  J Physiol       Date:  2014-02-10       Impact factor: 5.182

5.  Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.

Authors:  Jun Yoshino; Caterina Conte; Luigi Fontana; Bettina Mittendorfer; Shin-ichiro Imai; Kenneth B Schechtman; Charles Gu; Iris Kunz; Filippo Rossi Fanelli; Bruce W Patterson; Samuel Klein
Journal:  Cell Metab       Date:  2012-10-25       Impact factor: 27.287

6.  Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults.

Authors:  Rena M Pollack; Nir Barzilai; Valentin Anghel; Ameya S Kulkarni; Aaron Golden; Pilib O'Broin; David A Sinclair; Michael S Bonkowski; Alexander J Coleville; Danielle Powell; Sharon Kim; Ruin Moaddel; Daniel Stein; Kehao Zhang; Meredith Hawkins; Jill P Crandall
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-11-09       Impact factor: 6.053

7.  Status Epilepticus due to Intraperitoneal Injection of Vehicle Containing Propylene Glycol in Sprague Dawley Rats.

Authors:  Evon S Ereifej; Seth M Meade; Cara S Smith; Keying Chen; Nanette Kleinman; Jeffrey R Capadona
Journal:  Vet Med Int       Date:  2017-07-12

8.  Effects of Supplementation and Training on Ameliorating Lipid Profiles and Protection against Coronary Artery Disease; an Experimental Study.

Authors:  Reza Vafaee; Hamid Soori; Mehdi Hedayati; Hamid Reza Hatamabadi
Journal:  Arch Acad Emerg Med       Date:  2019-02-12

9.  Exploring the promise of resveratrol: where do we go from here?

Authors:  Jill P Crandall; Nir Barzilai
Journal:  Diabetes       Date:  2013-04       Impact factor: 9.461

10.  Resveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice.

Authors:  Geng-Ruei Chang; Po-Lin Chen; Po-Hsun Hou; Frank Chiahung Mao
Journal:  Iran J Basic Med Sci       Date:  2015-11       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.